MILESTONE PHARMACEUTICALS IN COM

MILESTONE PHARMACEUTICALS IN COM is a security (CUSIP 59935V107) tracked across SEC portfolio filings. 82 institutional managers reported $39.7M on Form 13F as of 2026-06-30; 2 registered fund positions totaling $80K via N-PORT as of 2026-05-31.

Summary

Top institutional holders (Form 13F)

Showing 15 of 82 managers by value.

ManagerLocationValueShares
RTW INVESTMENTS, LPNEW YORK, NY$7.5M6,331,001
Propel Bio Management, LLCLOS ANGELES, CA$5.1M4,118,321
Simplify Asset Management Inc.Las Vegas, NV$4.5M3,349,379
TWO SIGMA INVESTMENTS, LPNew York, NY$2.8M2,317,176
GOLDMAN SACHS GROUP INCNEW YORK, NY$2.4M2,000,025
MARSHALL WACE, LLPLONDON, X0$2.3M1,944,530
MILLENNIUM MANAGEMENT LLCNEW YORK, NY$1.8M1,544,325
Point72 Asset Management, L.P.Stamford, CT$1.3M1,085,683
Balyasny Asset Management L.P.Chicago, IL$1.0M851,325
Lion Point Capital, LPNEW YORK, NY$976K820,000
TORONTO DOMINION BANKToronto, Ontario, A6$893K750,000
MORGAN STANLEYNEW YORK, NY$862K724,141
AMERIPRISE FINANCIAL INCMINNEAPOLIS, MN$793K666,666
Boxer Capital Management, LLCSan Diego, CA$793K666,666
SUSQUEHANNA INTERNATIONAL GROUP, LLPBALA CYNWYD, PA$749K519,046

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Invesco NASDAQ Future Gen 200 ETFInvesco Exchange-Traded Fund Trust II$64K33.75%
Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Funds$16K0.04%

More